Urgency Urinary Incontinence Response Rates in Subjects With Overactive Bladder Treated With Fesoterodine 8 mg After Suboptimal Response to Tolterodine Extended Release 4 mg: A Randomized, Double-Blind, Placebo-Controlled Trial

Kaplan S A1, Herschorn S2, Carlsson M3, Ntanios F3

Abstract Category

Detrusor Overactivity

Abstract 546
Non Discussion Poster
Scientific Non Discussion Poster Session 34
Overactive Bladder Urgency Urinary Incontinence Clinical Trial Pharmacology
1. Weill Cornell Medical College, 2. Sunnybrook Health Science Centre - University of Toronto, 3. Pfizer Inc